VIDEO: New genetic research could identify Alzheimer’s therapy targets

COPENHAGEN – The National Institutes of Health recently awarded $24 million to eight academic centers to analyze the human genome and identify genes that either increase the risk of Alzheimer’s disease or have a protective effect.

It’s a very exciting time in Alzheimer’s disease genetics, said Marilyn Miller, Ph.D., program director of the National Institute of Aging’s Genetics of Alzheimer’s Disease, Tau, and Hormone Research portfolios in the division of neuroscience.

In a video interview at the Alzheimer’s Association International Conference 2014, Dr. Miller explains the ongoing research and the implications for potential therapies.

Alzheimer’s genetics research resources:

• The Alzheimer’s Disease Sequencing Project.

• The NIA Genetics of Alzheimer’s Disease Data Storage Site.

• The National Plan to Address Alzheimer’s Disease.

• The National Human Genome Research Institute.

[email protected]

On Twitter @naseemmiller

COPENHAGEN – The National Institutes of Health recently awarded $24 million to eight academic centers to analyze the human genome and identify genes that either increase the risk of Alzheimer’s disease or have a protective effect.

It’s a very exciting time in Alzheimer’s disease genetics, said Marilyn Miller, Ph.D., program director of the National Institute of Aging’s Genetics of Alzheimer’s Disease, Tau, and Hormone Research portfolios in the division of neuroscience.

In a video interview at the Alzheimer’s Association International Conference 2014, Dr. Miller explains the ongoing research and the implications for potential therapies.

Alzheimer’s genetics research resources:

• The Alzheimer’s Disease Sequencing Project.

• The NIA Genetics of Alzheimer’s Disease Data Storage Site.

• The National Plan to Address Alzheimer’s Disease.

• The National Human Genome Research Institute.

[email protected]

On Twitter @naseemmiller

COPENHAGEN – The National Institutes of Health recently awarded $24 million to eight academic centers to analyze the human genome and identify genes that either increase the risk of Alzheimer’s disease or have a protective effect.

It’s a very exciting time in Alzheimer’s disease genetics, said Marilyn Miller, Ph.D., program director of the National Institute of Aging’s Genetics of Alzheimer’s Disease, Tau, and Hormone Research portfolios in the division of neuroscience.

In a video interview at the Alzheimer’s Association International Conference 2014, Dr. Miller explains the ongoing research and the implications for potential therapies.

Alzheimer’s genetics research resources:

• The Alzheimer’s Disease Sequencing Project.

• The NIA Genetics of Alzheimer’s Disease Data Storage Site.

• The National Plan to Address Alzheimer’s Disease.

• The National Human Genome Research Institute.

[email protected]

On Twitter @naseemmiller